Int. J. Mol. Sci. 2013, 14(2), 3683-3704; doi:10.3390/ijms14023683
Review

NADPH Oxidase Biology and the Regulation of Tyrosine Kinase Receptor Signaling and Cancer Drug Cytotoxicity

Received: 24 December 2012; in revised form: 28 January 2013 / Accepted: 31 January 2013 / Published: 7 February 2013
(This article belongs to the Special Issue Redox Signaling in Biology and Patho-Biology)
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract: The outdated idea that reactive oxygen species (ROS) are only dangerous products of cellular metabolism, causing toxic and mutagenic effects on cellular components, is being replaced by the view that ROS have several important functions in cell signaling. In aerobic organisms, ROS can be generated from different sources, including the mitochondrial electron transport chain, xanthine oxidase, myeloperoxidase, and lipoxygenase, but the only enzyme family that produces ROS as its main product is the NADPH oxidase family (NOX enzymes). These transfer electrons from NADPH (converting it to NADP) to oxygen to make O2•−. Due to their stability, the products of NADPH oxidase, hydrogen peroxide, and superoxide are considered the most favorable ROS to act as signaling molecules. Transcription factors that regulate gene expression involved in carcinogenesis are modulated by NADPH oxidase, and it has emerged as a promising target for cancer therapies. The present review discusses the mechanisms by which NADPH oxidase regulates signal transduction pathways in view of tyrosine kinase receptors, which are pivotal to regulating the hallmarks of cancer, and how ROS mediate the cytotoxicity of several cancer drugs employed in clinical practice.
Keywords: NADPH oxidase; reactive oxygen species; cancer; tyrosine kinase receptors; cancer drugs
PDF Full-text Download PDF Full-Text [477 KB, uploaded 19 June 2014 04:42 CEST]

Export to BibTeX |
EndNote


MDPI and ACS Style

Paletta-Silva, R.; Rocco-Machado, N.; Meyer-Fernandes, J.R. NADPH Oxidase Biology and the Regulation of Tyrosine Kinase Receptor Signaling and Cancer Drug Cytotoxicity. Int. J. Mol. Sci. 2013, 14, 3683-3704.

AMA Style

Paletta-Silva R, Rocco-Machado N, Meyer-Fernandes JR. NADPH Oxidase Biology and the Regulation of Tyrosine Kinase Receptor Signaling and Cancer Drug Cytotoxicity. International Journal of Molecular Sciences. 2013; 14(2):3683-3704.

Chicago/Turabian Style

Paletta-Silva, Rafael; Rocco-Machado, Nathália; Meyer-Fernandes, José R. 2013. "NADPH Oxidase Biology and the Regulation of Tyrosine Kinase Receptor Signaling and Cancer Drug Cytotoxicity." Int. J. Mol. Sci. 14, no. 2: 3683-3704.

Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert